CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced ...

At the heart of innovation is T-win®, a groundbreaking vaccine platform that could change how we treat cancer.

A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't ...

In the quest to design vaccines that better help the body's immune system fight disease, scientists are always looking for ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

OSE Immunotherapeutics has shared survival data behind a therapeutic vaccine’s phase 2 pancreatic cancer win as the French ...

Adding IL-12, a cytokine produced by various immune cells, to mRNA vaccines improves T cell responsesThis could make the benefits of vaccines last ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...

A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by ...